Biomanufaktur Insulin Babi Rekombinan Indonesia

• Proses Mutakhir untuk Produksi Massal Insulin Babi

  Insulin babi adalah nama insulin sumber hewani yang artinya dari babi. Inilah sebabnya mengapa insulin ini bekerja sangat baik bagi penderita diabetes karena paling mirip dengan insulin manusia. Faktanya, para ilmuwan memproduksi insulin babi dengan melakukan biomanufaktur pada bakteri atau ragi. Setelah sel mengeluarkan insulin, para ilmuwan memanen cairan ini dari "cairan"), dan kemudian menjalani proses pemurnian. Mereka mampu membuat banyak insulin sekaligus, hal ini penting karena banyak orang membutuhkannya.

• Metode Biomanufaktur Insulin yang Efisien dan Berkelanjutan

  Penciptaan insulin melalui biomanufaktur adalah cara cerdas dan baru untuk menyelamatkan hewan. Ketergantungan pada sumber hewani dihilangkan dan sebagai hasilnya, harga insulin juga diturunkan sehingga lebih banyak orang mampu membelinya. Ini secara efektif memungkinkan lebih banyak insulin diproduksi secara total, sehingga tersedia banyak bagi siapa saja yang membutuhkannya. Ini juga merupakan solusi yang lebih ramah lingkungan karena menghemat banyak peternakan.

• Meningkatkan Akses terhadap Insulin dengan Produksi Insulin Babi Rekombinan

  Diabetes adalah penyakit kronis yang mungkin memerlukan pengobatan seumur hidup dan penggunaan insulin secara terus-menerus. Namun di banyak belahan dunia, insulin masih sulit dijangkau oleh mereka yang membutuhkannya. Ini mungkin karena harganya sangat mahal, atau mungkin bahkan tidak tersedia. Biopabrik insulin babi rekombinan, gambar dari web perusahaan bernama Dio-vi-life digunakan dengan izin untuk ilustrasi yang lebih imajinatif guna meningkatkan harapan dapat membantu mengakses DIRA ke skala yang lebih besar. Hal ini tidak hanya lebih hemat biaya dan lebih cepat dibandingkan metode tradisional berbasis hewani, namun juga berarti semakin banyak orang yang mampu membeli insulin yang dibutuhkan untuk membantu mengelola diabetes mereka.

Mengapa memilih Biomanufaktur Insulin Babi Rekombinan Yaohai?

• Kustomisasi, Efisiensi & Efektivitas Biaya

  Yaohai Bio-Pharma has experience in the production of biologics created from Recombinant Porcine Insulin Biomanufacturing. We offer customized RD and manufacturing solutions while making sure that there are no risks. We have been involved in diverse modalities such as subunit vaccines recombinant, peptides hormones, cytokines, growth factors, single-domain antibodies enzymes, plasmid DNA MRNA, and many more. We are a specialist in many microorganisms, including yeast extracellular and intracellular secretion (yields up to 15g/L) as well as bacteria intracellular soluble and inclusion body (yields as high as 10g/L). We have also created a BSL-2 fermentation platform to create bacterial vaccines. We focus on improving processes, increasing product yields, and reducing production costs. Utilizing a strong technology team, we can ensure prompt and reliable project delivery that will bring your product to market faster.

• Rantai Pasokan & Kemampuan Manufaktur yang Kuat

  Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have established an advanced facility that is equipped with modern facilities and strong RD manufacturing capabilities. We have five drug substance manufacturing lines that are in compliance with GMP requirements for microbial fermentation and purification, as well as two fill-finish lines that are automated for cartridges, vials, as well as pre-filled syringes. The available fermentation scales vary from 100L to 500L, 1000L and 2000L. Recombinant Porcine Insulin Biomanufacturing for vias are 1ml to 25ml, whereas the pre-filled syringes and cartridge filling specifications cover 1-3ml. Our production workshop is cGMP compliant and guarantees steady supply of clinical samples as well as commercial items. Our plant produces large molecules which are shipped to the globe.

• Sistem Mutu & Kepatuhan Terhadap Peraturan Global

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have a quality system which is in line with current GMP standards and international regulations. Our regulatory team is knowledgeable in global regulatory frameworks to accelerate biological launches. We ensure traceable manufacturing processes and top-quality products that are compliant with the requirements of the US FDA, EU EMA, Australia TGA, and Recombinant Porcine Insulin Biomanufacturing. Yaohai BioPharma has successfully passed the audit on site of the European Union's qualified Person (QP) for our GMP quality system and production site. In addition, we've cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Keahlian Profesional & Pengalaman Luas

  Yaohai Bio-Pharma is a leading Microbial biologics CDMO. We have been focused on microbial-produced therapeutics and vaccines for human, veterinary, and the management of pet health. We are equipped with Recombinant Porcine Insulin Biomanufacturing RD platforms as well as manufacturing technology that encompass the entire process beginning with the development of microbial strains cells, methods and processes, to commercial and clinical manufacturing which ensures successful implementation of cutting-edge solutions. We have acquired a large amount of experience in bio processing of microbial cells. We have delivered over 200 global projects, and help our clients with navigating the laws from the US FDA, EU EMA, Australia TGA, and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide tailored CDMO services.

Kategori produk terkait

Tidak menemukan apa yang Anda cari?
Hubungi konsultan kami untuk lebih banyak produk yang tersedia.